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Abstract
Background: Buruli ulcer (BU), caused by Mycobacterium ulcerans infection, is a debilitating disease of the skin and
underlying tissue. The first phase of a BU prevention and treatment programme (BUPaT) was initiated from 2005–2008, in
the Ga-West and Ga-South municipalities in Ghana to increase access to BU treatment and to improve early case detection
and case management. This paper assesses achievements of the BUPaT programme and lessons learnt. It also considers the
impact of the programme on broader interests of the health system.
Methods: A mixed-methods approach included patients’ records review, review of programme reports, a stakeholder forum,
key informant interviews, focus group discussions, clinic visits and observations.
Principal Findings: Extensive collaboration existed across all levels, (national, municipality, and community), thus
strengthening the health system. The programme enhanced capacities of all stakeholders in various aspects of health
services delivery and demonstrated the importance of health education and community-based surveillance to create
awareness and encourage early treatment. A patient database was also created using recommended World Health
Organisation (WHO) forms which showed that 297 patients were treated from 2005–2008. The proportion of patients
requiring only antibiotic treatment, introduced in the course of the programme, was highest in the last year (35.4% in the
first, 23.5% in the second and 42.5% in the third year). Early antibiotic treatment prevented recurrences which was
consistent with programme aims.
Conclusions: To improve early case management of BU, strengthening existing clinics to increase access to antibiotic
therapy is critical. Intensifying health education and surveillance would ultimately increase early reporting and treatment for
all cases. Further research is needed to explain the role of environmental factors for BU contagion. Programme strategies
reported in our study: collaboration among stakeholders, health education, community surveillance and regular antibiotic
treatment can be adopted for any BU-endemic area in Ghana.
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Introduction
In the absence of a proven strategy for preventing infection,
control of Buruli Ulcer (BU) relies on efficient health services to
prevent progression of pre-ulcerative conditions and treat ulcers.
According to the World Health Organisation (WHO), service
delivery is the primary function of any health system and entails
the provision of ‘‘effective, safe, good quality care to those that
need it with minimal waste’’, [1] and to address health care needs
through promotion, prevention, treatment and rehabilitation.
WHO defines a health system as ‘‘all organisations, people and
actions whose primary intent is to promote or to restore health’’
[1].
Buruli ulcer, caused by Mycobacterium ulcerans infection is a
debilitating disease of the skin and underlying tissue which starts as
a painless nodule, oedema or plaque and could develop into
painful and massive ulcers if left untreated [2]. It is the third most
common mycobacterial pathogen of humans, after M. tuberculosis
(tuberculosis) and M. leprae (leprosy), but the most poorly
understood [2,3]. Even though case fatality is low, morbidity is
high for all age groups [3–5] and the socio-economic implications
to the individual and cost of management to the health system are
enormous [6,7].
Surprisingly, estimates of Disability Adjusted Life Years
(DALYs) for Buruli ulcer, like other neglected tropical diseases
(NTDS) such as guinea worm, endemic syphilis and food-borne
trematode infections are not explicitly stated [8]. BU has been
reported in more than 33 tropical and sub-tropical climates
particularly West African countries [2,9], and Ghana reports an
average of 1000 cases each year [9]. The first case of BU was
reported in Ghana in 1972 in the Ga-district. [10]. A national case
search in 1998 indicated a national prevalence of 20.7/100,000
www.plosntds.org 1 June 2011 | Volume 5 | Issue 6 | e1187and a prevalence of 87.7/100,000 for the former Ga-district (now
the Ga-West and Ga-South municipalities), the fifth most endemic
in the country, yet with the highest burden in terms of healed and
active lesions [11].
The first phase of a BU prevention and treatment programme
(BUPaT) was initiated from 2005–2008, in the Ga-West and Ga-
South municipalities in the Greater-Accra region, Ghana, to
increase access to BU treatment and improve early case detection.
Before the inception of the BUPaT programme, surgery was the
main treatment for all BU patients. There was limited accessibility
to treatment since all surgeries had to be done at the Amasaman
hospital (AH), the main treatment and referral hospital for all BU
cases in the Ga-West municipality. Antibiotic treatment had not
been introduced and health staff had limited expertise in surgical
procedures and BU case management.
The BUPaT programme employed WHO-recommended
strategies which are: Building capacity of nurses and other para-
medical staff for effective case detection, and management at
designated health centres; training of community-based surveil-
lance volunteers (CBSVs), school teachers, other health workers
and traditional healers (THs), to enhance BU knowledge for early
detection; establishing a community-based surveillance system
with the help of CBSVs; compiling a database; providing surgical
and antibiotic therapy for all BU patients [12].
These strategies were undertaken by a health team that
consisted of staff of the national Buruli ulcer control programme
(NBUCP), the BUPaT programme from World Vision Ghana, the
health directorates of the Ga-West and Ga-South municipalities,
surgeons from the Korle-Bu teaching hospital in Accra, the
municipal school health education programme (SHEP) coordina-
tor, municipal environmental health officers (MEHOs), CBSVs,
THs and community members. This paper assesses achievements
of the BUPaT programme and lessons learnt for early case
detection, case management and access to treatment in a BU-
endemic rural area of Accra. It also considers the impact of the
programme on broader interests of the health system.
Methods
Study setting
This study was conducted from November 2008 to July 2009 in
the Ga-West and Ga-South municipalities. The Ga-West munic-
ipality shares boundaries with the Ga-South municipality to the
west. It has a population of 215,824 inhabitants of which 48.2%
are males and 51.8% are females. About 60% of the municipality’s
landscape is rural with about 200 scattered communities; 40% is
urban and peri-urban and is densely populated. The population of
the Ga-South municipality is estimated at 210,727 distributed in
362 communities. Like the Ga-West municipality, 48.2 %
inhabitants are males and 51.8% are females. The population is
mainly concentrated along the peri-urban areas of the municipal-
ity.
At the time of conducting the survey, the Ga-West and Ga-
South municipalities were known as the Ga-West District. The
Ga-West district covered the same geographical area as these two
municipalities (Ga-West and Ga-South). Through a government
legislative instrument, the Ga-West district was divided into two
separate municipalities in 2009 for easy governance and
accessibility of health services.
Since 1999, BU continues to be a major cause of morbidity in
both municipalities with increasing numbers of related disabilities.
Health services are provided by 3 main government health
centres, Weija hospital, Amasaman hospital (AH) and the Obom
Health Centre (OHC), a few private clinics, and family planning
and maternity homes.
Study design
The study employed a mixed methods approach using
quantitative and qualitative methods to assess the effectiveness of
the BUPaT programme in improving early detection and
management of BU in the Ga-West and Ga-South municipalities.
This approach provided the needed framework for obtaining,
understanding, comparing and cross-validating contextual infor-
mation from providers and beneficiaries of BU-related health
service delivery strategies. The various methods were complemen-
tary; emerging and divergent issues arising during the course of
one approach were clarified with another. Aside document reviews
which was ongoing over the course of the study, all the other
approaches followed sequentially.
Stakeholder forum (SF)
A day’s forum was held with thirty five (35) persons that
included the programme manager of the NBUCP, the municipal
chief executive (MCE) of the Ga-West municipality, some
municipal health staff, officials and BUPaT staff of World Vision
Ghana, doctors and nurses from the AH and the OHC, officials
from the Ghana education service, CBSVs and MEHOs. This
forum reviewed the BUPaT programme activities, explored issues
regarding health services delivery, capacity of health staff to deliver
BU-related services and the integration of programme activities in
communities and schools. Health service delivery interventions
such as the role of CBSVs in case detection, early reporting and
strengthening existing clinics in the community to increase access
to health services were discussed. Consideration was given to
community participation, sustainability of the programme as well
as the next steps for future strategies at BU control.
Documents review
Quarterly and annual BUPaT programme reports were studied
to provide background information and insights into programme
objectives, strategies and challenges.
Author Summary
Buruli ulcer (BU), caused by Mycobacterium ulcerans
infection, is a debilitating disease of the skin and
underlying tissue which starts as a painless nodule,
oedema or plaque and could develop into painful and
massive ulcers if left untreated. Using a combination of
quantitative and qualitative methods, the study assessed
the effectiveness of the BUPaT programme to improve
early detection and management of BU in an endemic area
in Ghana. The results of the study showed extensive
collaboration across all levels, (national, municipality and
community), which contributed to strengthening the
programme. Health staff were trained to manage all BU
cases. School teachers, municipal environmental staff and
community surveillance volunteers were trained to give
the right health messages, screen for detection of early
cases and refer for medical treatment. WHO-recommended
antibiotics improved treatment and cure, particularly for
early lesions, and prevented recurrences. Improving access
to antibiotic treatment is critical for early case manage-
ment. Health education is required to emphasise the
effectiveness of treatment with antibiotics to reduce
deformities and the importance of seeking medical
treatment for all skin lesions. Further research is needed
to explain the role of environmental factors in BU
contagion.
Health Services for Buruli Ulcer Control
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KIIs were held with the municipal health director (MHD) of the
Ga-West municipality, the programme managers of the NBUCP
and the World Vision Ghana, Ga-West municipality development
programme. These persons were selected because of their pivotal
role in the BUPaT programme. KIIs highlighted issues on access
to care, successes and challenges of the programme and
emphasised strategies requiring further strengthening.
Patients’ records review
Already analysed records of 297 patients from the AH were
reviewed to indicate the statistical trend, demographic character-
istics of patients, assess indicators of treatment procedures,
effectiveness of treatment and outcomes.
On-site clinic visits
Visits were made to the OHC and the Kojo Ashong clinic to
assess the effectiveness of decentralising treatment and manage-
ment of Buruli ulcer.
Focus group discussions (FGDs)
One FGD each was held in three randomly selected endemic
communities (Kojo Ashong, Avornyokope, and Balagono). Each
focus group was made up of 10 purposively selected persons,
comprising treated and discharged adults, and care-takers of child
patients. FGDs examined community perceptions about the
programme, school-based strategies, and the effectiveness of
medical treatment, particularly antibiotic treatment. FGDs also
considered challenges and concerns that were raised at the SF and
KIIs regarding low hospital/clinic attendance and late reporting.
Analysis of data
Information from BUPaT programme reports were subjected to
a thematic content analysis. Themes were derived from activities
that formed health service delivery strategies. Thematic related
activities, (community-based surveillance, community education,
school-based education and antibiotic therapy) were examined for
their contribution to awareness creation, access to timely
treatment, care and management of BU, and how best they
addressed the overall aim of the BUPaT programme. Consider-
ation was also given to the extent of collaboration and
coordination of activities among stakeholders. Documented
successes and challenges of the programme as well as those
mentioned at the SF and during KIIs and FGDs were noted.
Discussions and interviews from the SF and the KIIs were
subjected to a thematic content analysis. Interviews were
conducted in English and tape-recorded. During the interviews,
elaborate notes were taken and themes that emerged during these
discussions were noted. Subsequently, interviews were transcribed
using Microsoft Word. Transcriptions were translated and edited,
preserving the original style and context. The authors developed a
coding framework based on themes pertinent to the main features
and strategies of the BUPaT programme [13]. These themes
included ‘collaboration’, ‘health services’, ‘health education’,
‘access and utilisation’, ‘coverage’, ‘adequacy of facilities’,
‘antibiotics’, ‘surgery’, ‘complications’, ‘recurrence’, ‘patients’,
‘feeding’, ‘transportation’, ‘community’, ‘traditional healers’ and
‘community-based surveillance volunteers’.
FGDs were conducted and recorded electronically in the local
languages. Notes on content and context referred to recurring
themes. FGDs were translated into English and transcribed using
Microsoft Office Word. Similar to the procedure for analysing the
SF and the KIIs, transcriptions were subjected to a thematic
content analysis. A coding scheme was devised using themes that
clarified perceptions of health service delivery strategies and
medical treatment. These themes included ‘volunteers’, ‘treat-
ment’, ‘late treatment’, ‘traditional healers’, ‘herbal treatment’,
‘medicines’ and ‘costs’.
Observations during clinical visits were recorded in a notebook.
We paid attention to the type of treatment given to patients,
number of patients who received antibiotic care and documenta-
tion of patient data. Subsequently, clinical registers were examined
to ascertain the extent to which patients adhered to treatment.
Patient data captured on the WHO BU01 forms had already
been extracted and analysed by health staff and therefore there
was no need for any further analysis.
Ethics Statement
The study was approved by the ethical review committee of the
Ministry of Health, Ghana, and the ethics commission of Basel
(Ethikkommission beider Basel (EKBB)) in Switzerland. Verbal
consent was preferred to written ones since it did not pose any
psychological threat and reassured all interviewees of anonymity.
Both ethical review boards approved of verbal consent as long as
participation in the study was voluntary, participants had been
informed of the study aims and had the opportunity to ask
questions. Prior to the start of all interviews, interviewees were
informed about: the study aims, their rights to withdraw
participation from the study, the intended use of findings to
improve BU related health services and, for publications in
academic journals and reports. Informed verbal consent was
witnessed by two members of the BUPaT team who were not
members of the research team.
Results
Collaboration and networking of all partners and
stakeholders
Programme documents indicated that the BUPaT programme
was initiated by WVG and the MHD of the Ga-West
Municipality. The Municipal Chief Executive (MCE) of the Ga-
West Municipality and the NBUCP were engaged at the design
stage. At the onset, a Memorandum of Understanding (MOU) was
formalised with the MCE to ensure partnership with the local
government authorities, and subsequently the municipal health
staff and beneficiary communities. Table 1 shows a timeline of BU
activities in the country and study municipalities.
Programme documents, the SF and KIIs indicated a strong
partnership with the NBUCP which provided technical expertise
and training of health staff. To create awareness and ensure the
participation of civil society, programme documents revealed that
the BUPaT programme was duly launched at a durbar in the
capital of the municipality, Amasaman. THs, WVG staff, officials
from the NBUCP, municipal executives, health staff, teachers,
CBSVs, school children and community members were in
attendance.
Programme documents indicated that the core management
team of the programme was the WVG Ga-West municipality
manager, the MHD and the Municipal SHEP Coordinator.
Selection of members for this team was guided by the main
activities of the programme which were community and school
health education, screening, medical treatment, surgery and
wound care, community surveillance, documentation and compi-
lation of a patients’ database. Some individuals from the
Municipal Health Management Team (MHMT) served as focal
persons for various aspects of the programme. WVG too had a
focal person for the programme, officially known as the BUPaT
Health Services for Buruli Ulcer Control
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issues, logistics, monitoring, collation and analysis of patients’
records, and served as a liaison between WVG and the MHMT.
The MHD and the MHMT coordinated health activities related
to BU.
A coalition of stakeholders including health, environmental,
educational professionals, CBSVs and traditional rulers was
formed to ensure diversity of expertise as well as community
participation. As a practice, stakeholder meetings were organised
quarterly to report on the progress of the programme. Addition-
ally, a monitoring team comprising selected individuals from the
stakeholder group was constituted to evaluate programme goals
and objectives and follow-up on treated and discharged patients.
Training of health staff and other stakeholders for
increased awareness, case detection, community-based
surveillance and case management
According to programme documents, 120 CBSVs, 40 THs, 4
MEHOs and 113 teachers from 60 schools were trained to detect
early cases of BU in communities and refer promptly to health
facilities for treatment. BU information was included in the school
curriculum. Documents and narratives from the SF revealed that
officials from the NBUCP also trained 40 nurses in BU case-
detection, surveillance, wound care and prevention of disabilities
associated with BU. After training, these nurses were distributed
among the municipal health facilities: AH, OHC and two newly
opened health centres (one each at Dome Sampahman and Kojo
Ashong communities). Programme documents, the SF and KIIs
also revealed that refresher courses were held quarterly for nurses,
CBSVs and MEHOs. The NBUCP arranged for two surgeons
from the Korle-Bu teaching hospital to perform weekly surgical
operations on patients.
Health education, screening and community-surveillance
to improve early detection and treatment of cases
Programme documents indicated that the BUPaT programme
aimed to reduce BU-related suffering and disability through early
detection and treatment of pre-ulcer cases. The programme
therefore employed health education to create awareness,
screening and surveillance to detect all forms of BU, particularly
early cases to increase early reporting for medical care, antibiotic
care, wound dressing and surgery.
According to programme documents, AH staff and the SHEP
coordinator conducted BU education and screening in 80 schools.
Health staff, BUPaT programme staff and CBSVs combined
efforts to conduct health education in over 600 communities.
Sometimes these education campaigns culminated in BU screen-
ing. MEHOs also organised night-time film shows on BU and
followed up the next day for screening. CBSVs mounted intense
surveillance in their localities and paid random home visits to
screen and verify suspected cases of M. ulcerans infection.
Improved clinical treatment and case management of BU
Programme documents, the SF and KIIs revealed that the
WHO-recommended antimicrobial (rifampicin and streptomycin)
therapy was introduced at the beginning of the BUPaT
programme in 2005, and administered to all patients. Health staff
were trained in the appropriate protocols to be observed when
administering these antibiotics. By policy, BU treatment is covered
under the National Health Insurance Scheme (NHIS). Narratives
from the SF and the KIIs indicated that these antibiotics which are
anti-tuberculosis drugs were provided by the NBUCP. Medicines
and dressings were provided by the Ministry of Health through the
NBUCP and sometimes by World Vision Ghana when stocks were
exhausted. The SF forum also mentioned that surgery was carried
out at least once a week at the AH by a surgical team from the
Korle-Bu teaching hospital. Documents highlighted the infra-
structural limitations of the OHC and the Kojo Ashong clinic that
made it impossible for surgical operations to be carried out there.
At the Kojo Ashong clinic, located 20 kilometres from the AH,
in an endemic community, BU care was limited to antibiotic
therapy. At the time of the research team’s visit, 4 patients had
been registered: 2 female adults and 2 male children. During the
visit, the team observed treatment of the children and 1 adult. The
children proceeded to school after treatment. In addition to
antibiotic care, the OHC performs minor excisions; patients
requiring major surgery are referred to the AH. At the time of the
Table 1. Timeline of Buruli ulcer programmes and activities in Ghana.
Dates and References
1971 [4] First case of BU identified in a patient from the Ga district.
1989 [11] 96 cases of Buruli ulcer infection were discovered in the Asante Akim North District in the Ashanti Region of Ghana.
1993[18] A passive surveillance system for reporting Buruli ulcer was initiated in Ghana by the Ministry of Health.
July 1998[26] Signing of the Yamoussoukro declaration on Buruli ulcer in Yamoussoukro, La Co ˆte d’Ivoire, by the Director-General of the
WHO and Heads of State of Ghana, Benin and Co ˆte d’Ivoire. These governments agreed to mobilise resources to establish
national Buruli ulcer control programmes, conduct epidemiological surveys on BU and establish surveillance systems with
technical support from the WHO.
June-July 1999 [19] The Ghana Ministry of Health conducted a national case search on BU in the entire country. A total of 5,619 persons were
identified with BU lesions at various stages in all 10 regions of the country. The national prevalence rate was computed as
20.7/100,000 and the Ga-district prevalence rate was 87.7/100,000 for active lesions.
2002 [27] The establishment of the Ghana National Buruli ulcer Control Programme in accordance with the Yamoussoukro
declaration.
July – August 2005[21] Community-based study on knowledge, attitude and practice of Buruli ulcer conducted in the Ga-West district of Ghana.
2005 Buruli ulcer Prevention and Treatment Programme commenced in the Ga-West and Ga-South municipalities of the Greater
Accra region of Ghana.
March 2009[28] Cotonou declaration adopted in Cotonou, Benin, by the WHO Director-General, Minister of health, Ghana, other West
African presidents and participants, to take all the necessary measures to alleviate the suffering caused by Buruli ulcer, and
to contribute to further enhancement of knowledge about the disease.
doi:10.1371/journal.pntd.0001187.t001
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received treatment, though clinic records indicated that 24
patients (15 children and 9 adults) had been registered. Patient
records also showed that only those 9 registered patients had
regular treatment and they lived close to the OHC. Although
rehabilitation of patients with disabilities is an integral component
of BU care, all key informants admitted that this did not feature on
the programme’s agenda for lack of capacity and infrastructure.
One key informant explained:
We are exploring the possibility of referring patients who need to be
rehabilitated but who will pay for this service?
Compilation of a patient database
The NBUCP trained all health staff on the appropriate use of
the stipulated WHO BU01 forms to record patient information,
disease outcomes, and clinical and surgical procedures. Analysed
data from these forms indicate that 297 patients were treated from
June 2005 to June 2008. Children below 15 years constituted
nearly half (146; 49%) of all admissions over the 3-year period.
Patients presenting with ulcers formed the majority of all clinical
forms: 52 (52.5%) in the first, 62 (73%) in the second and 67 (59.3
%) in the third yearly periods. There were 14 (14%) patients with
recurring lesions (June 2005-May 2006) and none during the latter
yearly periods (Table 2).
Except for the last yearly period (June 2007-May 2008) where
only 34.5 % of patients healed without deformities, more than 60
percent of patients healed without deformities for the first and
second years (Table 3). The proportion of patients that reported
early and therefore were given only antibiotic treatment over the
programme period was encouraging, 35.4% in the first yearly
period, 23.5% in the second yearly period and 42.5%, in the third.
The programme recorded 4 BU-related deaths (Table 3). Utilisa-
tion of services for BU increased over the three-year period. Of the
297 BU patients treated during this period, 113 were treated in
year 3 (38.0%) compared with 85 (28.6%) in year 2, and 99
(33.3%) in year 1 (Table 3). Irrespective of these achievements, a
significant proportion of patients either absconded treatment, or
were lost to follow-up (14.1% in the first yearly period 9.4% in the
second yearly period and 14.2%, in the third) (Table 3).
Improving access to treatment by providing incentives to
surgeons; feeding and transport to patients
WVG provided cash incentives to plastic surgeons to ensure
continuity of surgical operations. It was apparent from programme
documents that the BUPaT programme supported in-patients and
in some cases relations or caregivers with two meals (breakfast and
lunch). Other organisations and individuals within and outside the
municipalities also contributed towards feeding of patients either
through cash donations or food items. All transport costs of
patients and accompanying CBSVs to the AH, OHC, and patients
who were referred to Korle-Bu hospital for specialised care were
reimbursed. Key informants remarked that although feeding and
refund of transport costs was not considered in the original
programme design, it had to be incorporated later taking into
consideration the poverty of programme beneficiaries, and
remarked that good nutrition enhanced the healing of wounds.
All 3 key informants and stakeholders highlighted the high costs
of treatment which placed a huge strain on the limited health
budgets of the municipalities. They perceived a major difficulty in
sustaining the programme if World Vision Ghana withdrew its
financial support especially in the absence of government
budgetary funding.
Achievements of the BUPaT programme
Among the contributions of the BUPaT programme to BU
control, the following achievements are notable: improved
collaboration among stakeholders, early case detection and
treatment, increased community awareness of the priority of BU
and improved access to treatment. Promoting awareness and
access to improved services has made it possible to minimise
surgical interventions, which the earlier programme had relied on
almost exclusively.
The priority of early detection and treatment highlighted in
programme documents (quarterly and annual reports), was
consistent with accounts in the SF, KIIs and FGDs. FGD
participants commended the community and school health
education programmes, use of media especially documentary
films and the efforts of the CBSVs. Participants regarded these
strategies as helpful for increasing their awareness, promoting
disease surveillance and encouraging early presentation of affected
persons for treatment. A participant at the SF summarised the
achievements of the programme as follows:
The success of this programme is due to the extensive collaboration and
networking of all those involved across all levels; national, municipality
Table 2. Patient characteristics and clinical forms of Buruli
ulcer (2005–2008).
Yearly periods *
2005–2006
(%)
2006–
2007(%) 2007–2008 (%)
N=99 N=85 N=113
Patient characteristics
Age
Less than 15years 56 (56.6) 40 (47.1) 50 (44.2)
15–49 38 (38.4) 38 (44.7) 52 (46.0)
Above 49 years 5 (5.1) 7 (8.2) 11 (9.7)
Sex
Male 41 (41.4) 41 (48.2) 62 (54.9)
Female 58 (58.6) 44 (51.8) 51 (45.1)
Clinical form
Nodule 22 (22.2) 3 (3.5) 18 (16.0)
Plaque 22 (22.2) 11 (13.0) 10 (8.8)
Oedema 2 (2.0) 7 (8.1) 7 (6.2)
Ulcer 52 (52.5) 62 (73.0) 67 (59.3)
Mixed 1 (1.0) 2 (2.4) 10 (8.8)
Osteomyelitis 0 (0.0) 0 (0.0) 1 (0.9)
Patient classification
New 85 (86.0) 85 (100.0) 113 (100.0)
Recurrent 14 (14) 0 (0.0) 0 (0.0)
Specimen taken for lab confirmation
Yes 15 (15.2) 19 (22.4) 28 (24.8)
No 84 (84.8) 66 (77.6) 85 (75.2)
Source: Patient data 2005–2008, Amasaman hospital.
*Since the BUPaT programme was initiated in June 2005, a yearly period was
calculated from June to May the next year.
doi:10.1371/journal.pntd.0001187.t002
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soldiers in the community and they have done extremely well in
surveillance, case detection and referral. They are the link between the
communities and the municipal hospital.
Our three key informants asserted the primary success of the
BUPaT programme in managing BU was best indicated by the
increasing number of patients receiving treatment at the AH over
the course of the programme period. Statistics from the Ga-West
municipality showed that prior to establishing the programme
there were 70 cases in 2001, 82 in 2002, 83 in 2003 and 71 in 2004
[14]. In 2005, when the BUPaT programme commenced, AH
recorded 99 cases and the number increased to 113 in 2008 over
the 3-year period of the programme.
Before the BUPaT programme, surgery and wound care had
been the only available treatment interventions. Improved
outcomes of antibiotic therapy have been highly valued by key
informants and stakeholders, who regarded it as a breakthrough.
Antibiotic treatment has been appreciated because it has
minimised recurrence of lesions, which was not possible under
the old treatment regime. FGD participants also valued the effect
of antibiotic therapy in shrinking lesions and removing necrotic
tissue (Figure 1). They made no mention of any negative side-
effects of this treatment.
Challenges of the BUPaT programme
Despite the achievements of the programme, stakeholders and
key informants mentioned some major challenges: the inadequacy
of ward space to accommodate affected persons who required
surgery, the lack of requisite infrastructure in other municipal
health centres to perform surgery and the limited health budgets of
municipalities. Another challenge was the delay of some affected
persons in seeking medical treatment. One stakeholder comment-
ed on the challenge of the AH as the main referral and treatment
facility for BU as follows:
We wish we could admit all the patients because some of them report
with bad ulcers. However, when there is no space, we can only tell them
to go back home and come daily for antibiotic treatment, which does not
make economic sense when you live so far away and are poor.
FGD participants mentioned fears of amputation, loss of
livelihoods and the inevitable long absence of the primary care-
giver from the home (mostly the mother), when a child is on
admission at the hospital, as reasons for delayed treatment. They
also expressed concern about feeding (the programme provided
two meals a day), transport costs (transport costs of care-givers
paying repeated visits to children on admission were not refunded)
and difficulties with the continuation of medical treatment if
support for feeding and transport was withdrawn. A mother of a
treated child explained:
When you realise that either you or your child has Buruli ulcer and you
choose to go to the hospital, you need to prepare financially because of so
many reasons: You will have to leave a family behind and you must
leave money to take care of them. When you are together as a family it is
very easy to cook and share, but when the family is not together it
Table 3. Treatment types, outcomes and surgical procedures for Buruli ulcer patients (2005–2008).
Yearly periods *
2005–2006 (%) 2006–2007 (%) 2007–2008 N (%)
N=99 N=85 N=113
Disability present on admission
Limitation present 14 (14.0) 19 (22.4) 32 (28.3)
No limitation present 85 (86.0) 66 (77.6) 81 (71.7)
Treatment types
Surgery only 37 (37.4) 4 (4.7) 0 (0.0)
Antibiotics only 35 (35.4) 20 (23.5) 48 (42.5)
Antibiotics and surgery 27 (27.3) 61 (71.8) 65 (57.5)
**Surgical procedures
Excision only 24 (37.5) 16 (24.6) 33 (50.8)
Skin grafting 36 (56.3) 41 (63.1) 28 (43.1)
Amputation 1 (1.6 ) 2 (3.1) 2 (3.1)
Wound debridement 3 (4.7) 6 (9.2) 2 (3.1)
Treatment outcomes
Healed without deformity 67 (67.7) 53 (62.4) 39 (34.5)
Referral 13 (13.1) 14 (16.5) 6 (5.3)
Healed with deformity 4 (4.0) 9 (10.6) 14 (12.4)
Absconded / lost to follow-up 14 (14.1) 8 (9.4) 16 (14.2)
Died, Buruli ulcer related 1 (1.0) 1 (1.2) 2 (1.8)
Still on admission 0 (0.0) 0 (0.0) 36 (31.9)
Source: Patient data 2005–2008, Amasaman hospital.
*Since the BUPaT programme was initiated in June 2005, a yearly period was calculated from June to May the next year.
**Surgical procedures explains treatment types for patients that had ‘surgery only’ and ‘antibiotics and surgery’.
doi:10.1371/journal.pntd.0001187.t003
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happens to my work when I am away taking care of a sick child; I will
lose money. It is easier to seek traditional care and pray it works.
However, other explanations for delayed medical treatment
were linked to misinformation from THs on the likelihood of
amputation with medical treatment. Some THs also tried to
convince affected persons that herbal treatment was more effective
than medical care. Stakeholders indicated that at the beginning of
the programme, THs were trained to identify and refer promptly,
all cases of BU that were brought to their attention, for
appropriate treatment but they acted contrariwise.
FGD participants also expressed difficulties in early diagnosis of
their conditions as BU, because of the various presentations of BU
infection. For many, it was difficult to know whether cuts, stings,
scratches and abrasions were uncomplicated injuries or the
beginning of the BU disease. In most cases, these were either
unnoticed or dismissed as trivial. As the condition progressed, an
assortment of remedies including herbs, balms and hot compresses
were applied until BU infection was established; in some cases,
after the affected part opened up (revealing the necrotic tissue).
Stakeholders’ suggestions for future services
Stakeholders regarded collaboration, networking and the
community-based surveillance system as vital components of the
BUPaT programme that had to be sustained. Stakeholders and
key informants also mentioned the need to equip existing clinics to
serve as treatment centres for wound care and antibiotic
treatment. This was considered important to improve access to
treatment and reduce severity of reported cases and disabilities,
thus reducing the cost burden to the health system.
FGD participants agreed that health education and community-
based surveillance activities should continue to increase awareness,
improve case detection and encourage early reporting. They also
implored the programme to continue to defray transport costs to
lessen the economic burden of the disease.
Discussion
The primary goal of the BUPaT programme was to reduce BU-
related suffering and disability through early detection and
treatment of cases. Using a mixed method approach, study
findings showed the contribution of the health system to BU
control in an endemic area in Ghana. Extensive collaboration
existed across all levels, (national, municipality and community),
which contributed to strengthening the health system. The
programme strengthened capacities of health staff in antibiotic
treatment and wound care, and trained teachers, MEHOs and
CBSVs in health education, screening, early detection and prompt
referral for medical treatment. A patient database was also created
using recommended WHO forms. WHO-recommended antibiot-
ics improved treatment and cure, particularly for early lesions,
thus preventing recurrences. Providing feeding and refund of
transport costs proved a useful strategy in encouraging medical
care. Irrespective of these achievements, there were still problems
of access, accommodation (lack of sufficient ward space), use of
traditional treatment, loss to follow-up and non-adherence to
treatment.
The broader impact of the BUPaT programme on the health
system could be seen in its effects on some of the six building
blocks, or subsystems, of the health system, but not on others. With
reference to the WHO framework [1], the programme mainly
affected governance, human resources, medicines and technology,
and health delivery; it had less impact on the financing and
information systems. Collaboration and networking among
stakeholders strengthened the governance sub-system and im-
proved health delivery of the programme. Training different
groups of stakeholders - namely, health staff, CBSVs, MEHOs,
teachers and THs - enhanced the human resource sub-system.
The administration of WHO-recommended antibiotics improved
treatment outcomes and revolutionised the medicines and
technologies sub-system. Each of these subsystems contributed to
improved health delivery. Minimising expensive surgery by
promoting alternative interventions reduced the strain on the
Figure 1. Resolution of Buruli ulcer using antibiotic treatment without surgery.
doi:10.1371/journal.pntd.0001187.g001
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programme now routinely compiles patient data using WHO-
recommended forms in an electronic database, community
epidemiological data are needed for an integrated data system
based on community surveillance.
Patient data showed that a significant proportion of admissions
comprise children under 15 years-of-age (49 %), consistent with
other study findings on the susceptibility of children to BU
infection [15,16]. Even though most cases of BU were not
confirmed by laboratory tests, all cases were diagnosed by qualified
health staff and surgeons on the basis of WHO clinical case
definitions [17]. The BUPaT project aimed to improve early case
detection, particularly for nodules, plaques and oedemas, though
patient data showed the proportion of patients with pre-ulcer
conditions remained less than for ulcer patients. Stakeholders
argued that this was not a failure of the programme, however,
because people with ulcers who would not previously have used
the health system were now seeking medical care instead of
remaining with THs.
Consequently, improved awareness has led to treatment of more
patients with both pre-ulcerative conditions and ulcers. The
reluctance of some people with BU to seek medical care is
consistent with findings of other studies [18–20]. Studies suggest
that the socio-economic impact of BU is a determining factor in
the choice of treatment and adherence to medical treatment [6,7].
Traditional therapy has been the first choice for treatment for
some affected persons because of easy local access, compared with
the burden of high transport costs, and loss of income due to
absence from work while in medical treatment at a distant site
[5,19,20].
Although increasing community awareness has been bringing
more patients to medical treatment, FGDs also showed that
various presentations (cuts, bites, stings and abrasions) were not
identified as a possible indication of M. Ulcerans infection that
would benefit from treatment. The effectiveness of antibiotics in
preventing recurrences was documented in the patient data.
Narratives from stakeholders and key informants referred to this,
and they also indicated satisfaction with the minimal cost of
antibiotic treatment compared with the high cost of surgery. These
findings are consistent with other studies on drug effectiveness
[2,21,22]. Even though there were no recurrent infections as
observed previously when surgery was the only treatment
procedure, a significant proportion of patients healed with
deformities, most of these patients had ulcers. To minimise
deformities, post-operative health care and physiotherapy is
required and prosthesis would be needed for amputees. The cost
of these services is indeed enormous for an already burdened and
poorly resourced rural health service [2,7]. WHO recommends
the need for rehabilitation of patients [23], yet there is paucity of
research on its success and integration in the health system.
Based on our study findings, we offer recommendations for
effective BU control, particularly for poorly resourced rural health
systems. These include health education and community surveil-
lance, collaboration with research laboratories for confirmation of
cases, improving access to antibiotic treatment and wound care,
integrating BU care with the management of similar diseases and
disease mapping:
Our findings show the tremendous impact of health education
and community surveillance strategies in BU control. Though this
is a laudable community-directed initiative, there is the need for
more concerted efforts of the programme to intensify these
strategies to reduce BU-related morbidity and increase timely
access to medical treatment. All teachers should be trained to
identify all forms of M. ulcerans infection and refer for medical
treatment. School children and others in the community should be
encouraged to identify and report suspected cases to teachers,
school authorities and community-based surveillance volunteers
for verification. Local political commitment is needed by involving
chiefs, traditional and religious leaders to support these efforts.
Health education messages should not only focus on creating
awareness. They should also emphasise the importance of early
reporting and appropriate care to avoid disease sequalae.
Messages should encourage affected persons to seek early medical
treatment for cuts, abrasions, stings or suspicious swellings. They
should correct local ideas about the cause of BU that may
discourage appropriate help-seeking. In this regard, it is important
that all suspicious pre-ulcerative lesions should be evaluated with
laboratory tests. WHO recommends a polymerase chain reaction
(PCR) test to confirm cases and diagnosis. Results of this test can
be obtained in two days [9]. Given the absence of infrastructure
and expertise to perform such analyses, the health system could
benefit from collaboration with research laboratories and
institutions.
The Ga-West municipality has opened health centres in a few
localities to make chemotherapy accessible but these have proven
woefully inadequate. There are quite a number of private clinics
and maternity homes in both municipalities managed by qualified
health personnel who have a large clientele. Integrating them in
the health system could boost coverage and access to chemother-
apy. The municipal health directorates should assume a
supervisory and monitoring role to ensure compliance to case
management and chemotherapy protocols.
The cost of managing BU like any other neglected tropical
disease is enormous and places a huge strain on a limited rural
health budget. Cost-effective interventions should aim at integrat-
ing diseases of similar characteristics. Since tuberculosis (TB) case
management relies on the Directly Observed Treatment Strategy,
all TB centres in the study municipalities could serve as referral
treatment centres for identified cases of M. ulcerans infection.
Understanding the demographics, epidemiology and geograph-
ical distribution of areas that require interventions is critical for
cost-effective BU control. The disease is known to be endemic in
riverine communities and is attributed to a myriad of factors that
include direct exposure to water and swampy areas [24,25]. These
features and documented cases could serve as indices for
classifying communities into three categories: priority-endemic
areas, requiring the most interventions, endemic and non-
endemic, requiring further research to enhance understanding of
the disease. First, basic demographic knowledge of all communities
must be documented, updated periodically and entered into a
central database that will enable mapping and tracking of cases.
This is a task for which spatial analytic research is needed.
Conclusions
Findings demonstrate the role of extensive health education,
community-based surveillance, capacity building and collabora-
tion among stakeholders for BU disease control. Treatment with
the administration of WHO-recommended antimicrobials has
proven effective at least for early lesions. Threats to livelihoods and
feeding and transport expenses influence delay to seeking medical
care. Findings also indicate the need for an integrated health
service delivery approach by incorporating diseases requiring
similar antibiotic treatment regimes. A further step towards
integration will be to include private health-care providers in the
health system to increase access to antibiotic therapy in close
proximity to the population. Health education is required in this
regard to emphasise the effectiveness of treatment with antibiotics
to reduce disease sequalae and the importance of seeking medical
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this study suggests that intensifying health education and
surveillance would ultimately improve access to treatment for all
cases. Further research is needed to explain the role of
environmental factors for BU contagion. Health service delivery
strategies reported in our study can be adopted for any BU-
endemic area in Ghana.
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